Catechol-O-Methyltransferase (COMT) is a critical regulator of catecholamine levels in the brain. A functional polymorphism of the COMT gene, val158met, has been linked to internalizing symptoms (i.e., depression and anxiety) in adolescents and adults. We extended this research by investigating whether the val158met polymorphism was associated with childhood symptoms of depression and anxiety in two independent samples of young children (Ns ¼ 476 and 409). In both samples, preschool-aged children were genotyped for the COMT val158-met polymorphism. Symptoms of psychopathology were assessed via parent interviews and primary caregiver reports. In both samples, children homozygous for the val allele had higher levels of depressive symptoms compared to children with at least one copy of the met allele. Our findings extend previous research in older participants by showing links between the COMT val158met polymorphism and internalizing symptoms in early childhood. Ó 2013 Wiley Periodicals, Inc.
INTRODUCTION
Depression and anxiety (i.e., internalizing disorders) are two of the most common forms of psychiatric disorder and constitute a bulk of the burden related to psychiatric disease [Reiger et al., 1993; Kessler et al., 1994; Olfson et al., 2002] . The etiology of these disorders is unclear but heritability estimates from twin cohorts suggest a substantial genetic component [Bierut et al., 1999; Eley and Stevenson, 1999; Kendler and Prescott, 1999; Kendler et al., 2006] . With respect to specific genes, the extant psychiatric genetics research implicates gene polymorphisms that regulate neurotransmitter release, transport and degradation [Krishnan and Nestler, 2010] in internalizing disorders. One such class of neurotransmitters is catecholamines, which include dopamine and epinephrine; optimal levels of catecholamines are critical in modulating sensory and motor responses and executive functions [Willner, 1995; Goldman-Rakic, 1998; Arnsten and Li, 2005; Brocki et al., 2009] . Animal models and studies of adult humans have consistently pointed to alterations in mesocorticolimbic catecholamine levels, and dopamine levels in particular, in depressive and anxious phenotypes [Pogorelov et al., 2005; Nestler and Carlezon, 2006; Ruhe et al., 2007; Dremencov et al., 2009] . For example, functional imaging research from human adults indicates that diminished cortical dopamine levels may play a role in behaviors related to some internalizing disorders, such as memory deficits, sleep and behavioral disturbances, and psychomotor retardation [Martinot et al., 2001; Fox et al., 2005; Golimbet et al., 2007; Demetrovics et al., 2010; Meyers et al., 2011; Meyer, 2012] .
Neuropsychiatric Genetics
Catechol-O-methyltransferase (COMT), a catabolic enzyme that degrades cortical catecholamines, including dopamine and epinephrine, plays a vital role in regulating mesocorticolimbic catecholamine levels [Meyer-Lindenberg and Weinberger, 2006] . The gene encoding COMT (Gene ID: 1312) is mapped to chromosome 22p11, and contains four exons [Brahe et al., 1986] . Further, a non-synonymous G ! A single nucleotide polymorphism (rs4680) in exon four leads to a valine (val) to methionine (met) peptide change in the mature protein, and is called the val158met polymorphism (GenBank accession no. Z26491). This substitution impacts the thermostability of the COMT protein and reduces the enzyme catabolic function, therefore reducing dopamine degradation in carriers with at least one copy of the met allele by more than one-third compared to carriers homozygous for the val allele [Lotta et al., 1995; Lachman et al., 1996; Chen et al., 2004] .
Due to the functional nature of the COMT val158met polymorphism on cortical dopamine levels, links between COMT and internalizing disorders have been extensively explored in adult psychiatric populations. For example, Hamilton et al. [2002] reported a strong association between the COMT val158met polymorphism and panic disorder in a family-based sample of 70 panic disorder pedigrees and 83 parent-offspring triads. According to Massat et al. [2005] , the val allele is associated with early-onset major depression, and others have shown that this variant may increase risk for panic disorders and anxiety [Rothe et al., 2006; Domschke et al., 2007; Hos ak, 2007] . Finally, Hettema et al. [2008] showed that the COMT val158met polymorphism is part of a genetic risk haplotype shared across a range of internalizing disorders, including major depression, anxiety and panic disorder. Even though multiple studies have reported on links between the COMT gene locus and internalizing phenotypes, there is disagreement in the adult literature on which COMT val158met allele confers risk. There are a few reports where the link between this polymorphism has either failed to replicate [Middeldorp et al., 2010; Opmeer et al., 2010] or have identified the met allele as the risk allele for internalizing disorders [Baekken et al., 2008; Wray et al., 2008; Aberg et al., 2011] .
Researchers have posited that the inconsistencies in this literature stem from a number of factors, including lack of statistical power to detect genetic associations, as most studies have used small samples (i.e., fewer than 200 subjects) [Chen et al., 2011] . There is strong agreement in the literature on the need for larger samples, and, more importantly, replication of genephenotype associations in independent samples [Ioannidis et al., 2001; Zintzaras and Lau, 2008; Bosker et al., 2011] . Furthermore, to better understand the etiology of internalizing disorders, theorists emphasize the need for study designs that investigate the early developmental origins of these conditions [ZahnWaxler et al., 2000] . Early childhood is a period of critical brain development when cortical and limbic regions, and the dopaminergic neurotransmitter system in particular, are undergoing maturation through processes such as neuronal synaptogenesis, myelination, and synaptic pruning [Sowell et al., 2003 ]. This period of increased brain plasticity is thought to influence sensory and perceptual functions that may have long-term consequences for shaping adaptive and maladaptive behavior [Nestler et al., 2002; Sowell et al., 2003; Krishnan and Nestler, 2010] . It is important to note that longitudinal studies have shown continuities between internalizing symptoms from childhood to adolescence and recurrence of depression in adult life [Bardone et al., 1996; Lavigne et al., 1998; Hofstra et al., 2000; Woodward and Fergusson, 2001; Fergusson and Woodward, 2002] , suggesting that research identifying early-emerging risk markers for depressive symptoms may have important preventative implications. However, little work has been done on appropriate candidate genes, such as the COMT val158met, and emerging internalizing symptoms in early-life.
The aim of this study is to examine links between the COMT val158met polymorphism and early-emerging internalizing symptoms. Due to the important role of the COMT enzyme in the brain's catecholamine metabolism, we hypothesized that functional polymorphisms of this gene would be associated with symptoms of anxiety and depression in preschoolers. Furthermore, based on findings from adult samples, we tentatively hypothesized that the val allele of the COMT functional polymorphism would be associated with higher levels of internalizing symptoms. To increase confidence in our findings, we tested these hypotheses in two independent samples of preschoolers. Table I lists the demographic information for the study samples. The primary sample (hereafter referred to as Study 1) consisted of 559 children and their parents residing in Long Island, NY, USA. Of these, 476 children (254 males) contributed DNA and were therefore available for genetic analysis. Children's mean age was 42.2 months (SD ¼ 3.1). Most participants came from middle-class families (M ¼ 44.8; SD ¼ 10.9), as measured by Hollingshead's Four Factor Index of Social Status [Hollingshead, 1975] . Children were of average cognitive ability (M ¼ 103.1, SD ¼ 13.7), indexed by the Peabody Picture Vocabulary Test [PPVT-4, Dunn and Dunn, 1997] .
METHODS Participants

Replication Sample
In this sample (hereafter referred to as Study 2), participants were an unselected community sample of 409 (201 males) children and their primary caregivers (93% were the child's mother) from southwestern Ontario, recruited for a larger study of genetic and other biological and contextual influences on child temperament and psychopathology risk. Children's mean age was 36.2 months (SD ¼ 0.16). Over half of participants (50.4%) in this sample also came from middle-income families with family income ranging from $40,000 to $100,000 CAD (see Table I for further details). The family demographic data for this sample closely resembles the most recent London, Ontario census data available [Statistics Canada, 2006] . Children were administered the PPVT-4 to screen for gross cognitive impairment and English proficiency (M ¼ 112.4, SD ¼ 14.8).
Informed consent was obtained from the parent prior to participation. Both studies were approved by the respective university's human subjects ethics review committees.
Genotyping
Genomic DNA was purified from buccal swab cellular extracts and stored according to manufacturer instructions (Qiagen, Valencia, CA). Following Ruiz-Sanz et al. [2007] , an allele-specific PCR detection method was used to determine the COMT val158met genotype. Briefly, allele specific primers containing specificity enhancing mismatches, 5 0 -CGGATGGTGGATTTCGCTGaCG-3 0 (G-allele specific) and TCAGGCATGCACACCTTGTCCTTtAT (A-allele specific), were used in the presence of control primers to amplify allele specific amplicons. The PCR conditions used were: 5 min of initial denaturation at 948C followed by 30 cycles of 30 sec of denaturation at 948C, 30 sec annealing at 628C and 20 sec of extension at 728C, followed by a final extension of 5 min at 728C. To improve reaction fidelity, we used the Invitrogen PCRx Enhancer (Invitrogen, Carlsbad, CA) as an adjuvant in our PCR amplifications. Amplicons were separated on 6% polyacrylamide gels, visualized using ethidium bromide and documented using the Bio-Rad 2000 gel documentation system (Bio-Rad Laboratories, Mississauga, ON, Canada). All genotyping was performed by technicians unaware of other study data.
In Study 1, 141 children (34.1%) were valine homozygous, 199 (48.2%) were heterozygous, and 73 (17.7%) children were homozygous for the methionine substitution. These genotypic frequencies are in Hardy-Weinberg equilibrium (c 2 ¼ 0.04; P ¼ 0.85). In Study 2, 118 children (29.4%) were valine homozygous, 190 (46.3%) were heterozygous, and 93 (23.2%) children were homozygous for the methionine substitution, also in Hardy-Weinberg equilibrium (c 2 ¼ 0.95; P ¼ 0.33). Behavior measures. In Study 1, the Preschool Age Psychiatric Assessment [PAPA; Egger et al., 2006 ] Version 1.4 was used to assess symptoms of psychopathology as defined by Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria [American Psychiatric Association, 2000] relevant to children in this age group. The PAPA is the first published diagnostic interview to assess parent-reported psychopathology in children between the ages of 2 and 5 years. It uses a structured format and an interviewerbased approach. Symptoms occurring 3 months prior to the interview are rated to enhance accurate recall. Adequate test-retest liability has been reported (range of intra-class correlations [ICC] for dimensional symptom scores ¼ 0.56-0.80, median ¼ 0.66, Egger et al. [2006] ). For this study, we used PAPA indices of depressive and anxious symptoms. We also used symptoms of oppositional defiant disorder (ODD) and attention deficit/hyperactivity disorder (ADHD) to determine whether the COMT genotypes were related specifically to depressive and anxious symptoms or general manifestations of psychopathology.
The PAPA depression scale included ratings for any depressive disorder, that is, major depressive disorder, dysthymia, or depression not otherwise specified. Similarly, the anxiety disorder scale was created summing ratings from specific phobia, separation anxiety, social phobia, GAD, agoraphobia and panic disorder items. Dimensional scores were created by summing the ratings of all items included in the algorithms created by Egger et al. [2006] to derive child's depressive and anxiety symptoms and symptoms of ODD and ADHD.
Interviews were conducted by advanced graduate students in clinical psychology who received training on the administration of the PAPA from a member of the PAPA group. To examine interrater reliability, a second rater independently rated audiotapes of 21 PAPA interviews. ICCs for the symptom scales used in this study were as follows: depression (0.85), anxiety (1.00), ODD (0.99) and ADHD (0.99). Internal consistency (a) was calculated for each symptom scale and indicated good reliability for depression (a ¼ 0.75), anxiety (a ¼ 0.83), ODD (a ¼ 0.84), and ADHD (a ¼ 0.89). According to the PAPA, the number of children meeting the DSM-IV diagnosis threshold for each disorder were 23 (4.9%) for MDD, 3 (0.7%) for GAD, 50 (12%) for ODD and 13 (3.1%) for ADHD.
In Study 2, symptom data were obtained by having the child's primary caregiver complete the Early Childhood Inventory-4 [ECI-4; Gadow and Sprafkin, 1997] . The ECI-4 is a 108-item behavior rating scale that assesses symptoms of 15 DSM-IV childhood emotional and behavioral disorders. The ECI-4 has shown satisfactory test-retest reliability, as well as concurrent and predictive validity [Sprafkin et al., 2002] . For the present study, symptom severity scores for depression, anxiety, ODD, and ADHD were created. Symptom severity scores were created by summing all symptoms rated as occurring ''never'' (coded as 0) ''sometimes'' (coded as 1) ''often'' (coded as 2) or ''very often'' (coded as 3) [Gadow and Sprafkin, 1997] . The depression scale was created using items similar to the PAPA, that is, symptoms of major depressive disorder, dysthymia, or depression not otherwise specified were considered (M ¼ 5.14, SD ¼ 2.97; range of number of symptoms ¼ 0-8). Similarly, the anxiety disorder scale was created by summing the scores of all anxiety disorders measured (separation anxiety disorder, specific phobia, obsessions, compulsions, generalized anxiety disorder, social phobia, and PTSD (M ¼ 16.08, SD ¼ 6.42; range of number of symptoms ¼ 4-34). The total number of possible symptoms was 11 for the ECI-4 depression scale and 44 for the anxiety scale.
Data Analyses
First, associations were examined between COMT genotypes and child psychopathology symptoms on the PAPA (Study 1) and ECI-4 (Study 2). These associations were tested under dominant, recessive and co-dominant models for the ancestral allele (val allele). To address potential population stratification, we conducted our analyses on the Caucasian participants based on parent-reported ethnicity in both samples. After excluding non-whites, for final analysis, we had 413 and 362 (of the 371 children in Study 2, genotype data was missing for nine children) from Study 1 and Study 2, respectively. 1 As some children had no parent-reported symptoms, we used nonparametric tests (Mann-Whitney U-test) for some analyses as needed. All tests were conducted using PASW 18.
RESULTS
Symptoms were unassociated with demographic variables such as child gender and socio-economic status in either sample (all ps > 0.56). No associations between COMT genotypes and child gender (all ps > 0.10) or socioeconomic status were found in either sample (all ps > 0.55). In Study 1, we found significant associations between COMT genotypes and PAPA symptoms of depression (Z ¼ À2.82, P ¼ 0.01) and anxiety (Z ¼ À2.27, P ¼ 0.02) under a valine recessive model (Table II) . The COMT val158met polymorphism was associated with child internalizing symptoms assessed by the PAPA, such that children with at homozygous for the val allele had significantly higher symptoms of anxiety and depression (all ps < 0.05). In contrast, the two COMT val158met allelic groups did not differ significantly on ODD (Z ¼ À0.79, P ¼ 0.42) and ADHD symptoms (Z ¼ À0.004, P ¼ 0.99).
Table II also shows associations between COMT val158met genotype and primary caregiver reported emotional and behavioral symptoms on the ECI-4. Consistent with the results from Study 1, we observed positive associations between child depressive symptoms and the COMT val158met genotype under a val recessive model (Z ¼ À2.19, P ¼ 0.03). According to primary caregiver reports, val homozygotes exhibited higher symptoms of depression than children with at least one copy of the met allele. The relationship between val158met genotypes and anxiety symptom reports on the ECI-4 reached only a trend level (Z ¼ À1.66, P ¼ 0.10). No associations were found between COMT genotype and externalizing symptoms such as ODD (Z ¼ À1.02, P ¼ 0.22) and ADHD (Z ¼ À0.75, P ¼ 0.45).
DISCUSSION
We examined whether the COMT val158met gene polymorphism was associated with psychopathological symptoms in preschoolers [Hollingshead, 1975] ; PAPA, Preschool Age Psychiatric Assessment; ECI-4, Early Childhood Inventory-4 [Gadow and Sprafkin, 1997] ; COMT, catechol-O-methyltransferase; val, valine; met, methionine. Mean ranks were tested using Wilcoxon rank sum test, as symptom scores were not normally distributed due to absence of internalizing symptoms in some children. These children received a score of ''0'' on the relevant symptom sub-scale on the PAPA and ECI-4. a Symptom data based on maternal interview reports from the PAPA.
b Primary caregiver reports from the ECI-4. *P < 0.10. **P < 0.05. ***P < 0.01.
1
Demographic information for the Caucasian sub-set of the study sample is provided as supplementary table.
in two separate samples. Findings from both samples indicate that the COMT val158met functional polymorphism is associated with symptoms of depression (and anxiety in one of the samples) in young children but not with child externalizing symptoms. More specifically, our analysis shows that children homozygous for the val allele have more depressive symptoms than children with at least one copy of the met allele. These findings are consistent with recent association studies in samples of young children [Drury et al., 2010] , adolescents [Wahlstrom et al., 2007; Nobile et al., 2010] and adults [Enoch et al., 2003; McGrath et al., 2004; Massat et al., 2011] , in which the val allele was associated with significantly higher anxious and depressive symptoms. The associations we found may be mediated by the influence of the COMT genotype on dopamine function in the brain, which has been implicated in neurobiological models of depression. Dopamine plays a critical role in synaptic plasticity through multiple mechanisms. For example, it controls the activity of AMPA and NMDA receptors through phosphorylation, and it also regulates voltage-gated ion channels such as sodium and calcium channels by affecting their phosphorylation state as well [Girault and Greengard, 2004] . The increased clearing of dopamine in val homozygotes may affect synaptic plasticity through secondary mechanisms involving AMPA and NMDA receptor activity, which may lead to cognitive and other deficits, and thus increased depressive and anxious symptoms. While speculative, some observations support this hypothesis; for example, in a recent study of a community sample of pre-adolescent children, met carriers performed better on prefrontal-dependent tests of cognition such as working memory tasks [Barnett et al., 2007] . Data from functional neuroimaging studies also show decreased prefrontal activation in the val homozygotes compared with the met carriers while completing tests of executive function [Mier et al., 2010] . In light of the fact that both decreased prefrontal activation and early cognitive deficits, such as poor performance on working memory tasks, have been consistently associated with increased risk for both anxiety and depression later in life [see Drevets et al., 2008; Gotlib and Joormann, 2010; Marazziti et al., 2010, for reviews] , genetic influences on cognition may shape one early-emerging pathway to internalizing disorder. The relationship between the genotypes and anxiety symptoms was found only at the level of a trend in Study 2. This could be related to differences in assessment approaches between the two studies. More specifically, interview-based measures, such as the PAPA, are conducted by trained interviewers and may therefore afford greater statistical power to detect genotype-phenotype associations by decreasing measurement error with respect to the phenotype.
Our findings are contrary to some reports in the adult literature indicating that the met allele increases risk for internalizing disorders [Baekken et al., 2008; Wray et al., 2008; Aberg et al., 2011] , and studies that show no effect for this gene polymorphism at all [Middeldorp et al., 2010] . Some have posited that the failures of replication and inconsistent nature of findings regarding the COMT val158met polymorphism in adults could be due to confounding influences such as sex, ethnicity, and current or previous history of mental disorders. First, with regard to sex, COMT enzyme activity differs greatly in adult males and females, with females having significantly lower prefrontal cortex COMT activity [Chen et al., 2004] ; furthermore, some data indicate that estradiol acts as a regulator of COMT expression in adult females [Karayiorgou et al., 1999; Worda et al., 2003] . Therefore, the influence of estradiol may be an important confound in studies exploring links between the COMT polymorphism and internalizing symptoms in adults that has not been consistently or effectively addressed in study designs. Second, in a recent meta-analysis, Domschke et al. [2007] found ethnicity-specific associations between COMT gene and internalizing disorders, with Caucasian adults homozygous for the val allele exhibiting greater internalizing problems; in contrast, the met allele carriers of Asian descent reported higher internalizing problems. Taken together, the use of an ethnically homogenous sample of preschoolers may have helped us minimize these possible confounds.
A major strength of our study is the use of two independent samples to investigate links between the COMT val158met polymorphism and depressive symptoms, but our study also had a few limitations. Although we conducted our associations in an ethnically homogenous sample, population stratification could still be a factor, although experts differ in opinion regarding the impact of population stratification [Hutchison et al., 2004] . It is also plausible that other functional polymorphisms flanking the COMT SNP could be in linkage-disequilibrium with these loci and may lead to type I errors, but the functional nature of this polymorphism, and the replication of our results, makes this an unlikely possibility. Furthermore, complex phenotypes such as depression and anxiety are influenced by the interplay of many different genes [Reif and Lesch, 2003] . Therefore, the role of the dopamine system in the development of internalizing disorders is likely regulated by the interaction between multiple genes [see Opmeer et al., 2010 for an overview]. Other genetic variation such as epigenetic regulation of genes involved in catecholamine metabolism has also been hypothesized as a possible contributor to the development of complex traits such as depression. Recent evidence indicates that epigenetic variation such as promoter CpG methylation of the COMT gene effects COMT mRNA status and translation of both soluble and membrane bound COMT enzyme [Mill et al., 2006] . It is therefore plausible that interindividual differences in methylation status of the COMT gene promoter region may be linked to emerging symptoms of psychopathology. Finally, we did not explore the interactions between the COMT val158met polymorphism and early childhood environment. It is likely that some of the emerging clinical symptoms we report are an outcome of interactions between this polymorphism and early childhood environmental contexts. In a recent study in preschoolers exposed to early social deprivation, Drury et al. [2010] reported fewer symptoms of depression in met allele carriers as compared to their homozygous val allele counterparts. Our data complements the work of Drury et al. [2010] by showing that the importance of COMT functional variation and its links to emerging internalizing phenotypes. The relationship between this polymorphism and early life environment seems to be context specific as Evans et al. [2009] found no evidence of interaction between this locus and maternal depression as predictor of childhood internalizing symptoms. Indeed, future research designs should explore interactions between this polymorphisms and additional early life contexts such as parenting behaviors as predictors of emerging psychopathology. In spite of these limitations, we believe that the current study makes an important addition to the literature on molecular genetics of internalizing phenotypes. To our knowledge, this is the first study of its kind to report and replicate associations between COMT val158met polymorphism and early-emerging depressive symptoms.
